Greg Dubrowny

Title: Greg Dubrowny: Innovator in Pharmaceutical Tablet Technology

Introduction

Greg Dubrowny is a notable inventor based in Garfield, NJ (US). He has made significant contributions to the field of pharmaceutical technology, particularly in the development of tablet formulations for poorly compressible drugs. His innovative approach has led to advancements that enhance the efficiency and effectiveness of drug delivery systems.

Latest Patents

Greg Dubrowny holds a patent for a binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability. This patent describes a process where tablets of a poorly compressible drug are made by direct compression using a binder composition that is a polymer, preferably a copolymer of polyvinylpyrrolidone (PVP) and vinyl acetate (VA). The binder composition has a defined glass transition temperature (Tg) and is admixed with a plasticizer, such as an organic ester or polyol, which reduces the Tg of the copolymer by at least 10° C. This innovative method allows for the direct compression of the binder composition and the drug into a tablet with predetermined hardness and friability, using an acceptable compression force.

Career Highlights

Greg Dubrowny is associated with Isp Investments Inc., where he applies his expertise in pharmaceutical formulations. His work has been instrumental in advancing the technology used in the production of tablets, making them more effective for patients who require poorly compressible drugs.

Collaborations

Greg has collaborated with notable colleagues, including Rama K Haldar and John N Zamora, who have contributed to his research and development efforts in the pharmaceutical industry.

Conclusion

Greg Dubrowny's innovative work in the field of pharmaceutical technology has led to significant advancements in tablet formulations. His contributions continue to impact the industry positively, enhancing drug delivery systems for better patient outcomes.